secwatch.observer — SEC 8-K summary
======================================

Issuer:     CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK:        0001369568
Form:       8-K
Filed at:   2023-08-25T23:59:59+00:00
Accession:  0001193125-23-221544
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Catalyst Pharma elects seven directors at annual meeting; Philip Coelho retires from board
--------------------------------------------------------------------------------

- Patrick J. McEnany, Richard J. Daly, Donald A. Denkhaus, Molly Harper, Charles B. O’Keeffe, Tamar Thompson, and David S. Tierney elected to board for 2024 term.
- Philip H. Coelho, board member since 2002, did not stand for re-election; retirement not due to any disagreement.
- Shareholders approved amendment to 2018 Stock Incentive Plan with 73.2M for, 2.7M against.
- Advisory vote on named executive officer compensation passed with 72.6M for, 2.9M against.
- Ratification of Grant Thornton as auditor for FY2023 approved with 87.6M for, 0.3M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1369568/000119312523221544/0001193125-23-221544-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1369568/000119312523221544/d540429d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-221544

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer